Neurovascular Embolization Market Analysis

Neurovascular Embolization Market Analysis

To get key market trends

  Download Free Sample

The market by product is categorized into embolic coils, flow diversion devices, liquid embolic agents/systems, aneurysm clips and intrasaccular flow disruptors. The embolic coils segment garnered USD 907 million revenue size in the year 2022.

• The dominance of the embolic coils segment is attributed to its proven clinical efficacy, minimally invasive nature, versatility, and ongoing technological advancements. These coils effectively treat cerebral aneurysms and other neurovascular conditions, instilling confidence among healthcare professionals and patients.
   
• Additionally, high patient satisfaction, growing awareness, and education in the field have solidified their position as the preferred choice for effective and safe treatment.
   

Based on procedure, the neurovascular embolization market is segmented into aneurysm coiling and embolization, arteriovenous malformation (AVM) embolization, and other procedures. The aneurysm coiling and embolization segment dominated the market and accounted for over 59% business share in the year 2022.
 

• High segment growth is attributed to the rising prevalence of intracranial aneurysms and the effectiveness of these minimally invasive procedures in treating them.
   
• Furthermore, the high success rate, shorter recovery time, patient and provider preference, ongoing technological advances, an aging population base at higher risk, increased awareness, and substantial R&D investments continue to drive the dominance of aneurysm coiling and embolization in the market.
   

The neurovascular embolization market by end-use is categorized into hospitals, specialty clinics, and other end-users. The hospitals garnered USD 894 million revenue size in the year 2022.
 

• The dominance of the segment is attributed due to their specialized care capabilities, advanced imaging resources, emergency support, and multidisciplinary teams.
   
• Furthermore, their access to critical care units, comprehensive resources, insurance partnerships, and roles in research and education make them the preferred choice for neurovascular interventions, establishing their market supremacy.
   

The U.S. neurovascular embolization market accounted for USD 503 million revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline.
 

• The U.S. has taken a commanding position in the market, primarily due to its advanced healthcare infrastructure, coupled with a high prevalence of neurovascular conditions, positions it as a hub for cutting-edge embolization procedures.
   
• Additionally, the strong regulatory framework provided by institutions such as the FDA instills confidence in both patients and healthcare providers, firmly establishing the U.S. as the market leader.